Impact of the passive immunization campaign with nirsevimab in 2023¿24 in Castellón. Final results Eulalia Gregori-García; Juan Carlos Gascó-Laborda; Lledó Lluch-Bacas; Oscar Pérez-Olaso; Iris Gómez-Alfaro; Juan B. Bellido-Blasco;

Impact of nirsevimab immunization on RSV infections attended in the pediatric emergency department: First results in a tertiary hospital in Madrid Miguel Ángel Molina Gutiérrez; Begoña de Miguel Lavisier; José Antonio Ruiz Domínguez; María García de Oteyza; Virginia María Velasco Molina; Almudena Gutiérrez Arroyo; María de Ceano-Vivas;

Effectiveness of immunization strategies for preventing severe acute respiratory infection during the 2023/2024 season in a Spanish health department Raíssa de Fátima Silva-Afonso; Guillermo Platas-Abenza; María Guerrero-Soler; Pilar Gallardo-Rodríguez; Francisco Gil-Sánchez; Gonzalo Pérez-Paz; Lidia Cartagena-Llopis; Marina Fuster-Pérez; María Sánchez-Valero; Ana Esclapez-Martínez; Noemí Solís-Aniorte; Yamilet Fernández-Martínez; Elena Ronda-Pérez; Isabel Escribano-Cañadas; Juan Carlos Rodríguez-Díaz; Esperanza Merino De Lucas; Pablo Chico-Sánchez; José Sánchez-Payá; Paula Gras-Valentí;